Literature DB >> 14938753

A study of the complement fixation reaction in histoplasmosis.

J T GRAYSTON.   

Abstract

Keywords:  HISTOPLASMOSIS/diagnosis

Mesh：

Year:  1952        PMID： 14938753

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  8 in total

1.  Evaluation of histoplasmin and yeast phase antigens derived from a single strain of Histoplasma capsulatum in the complement fixation test.

Authors:  J H SCHUBERT; L AJELLO; J S COOPER; L C RUNYON
Journal:  J Bacteriol       Date:  1955-05       Impact factor: 3.490

2.  Histoplasmosis.

Authors:  C W EMMONS
Journal:  Bull N Y Acad Med       Date:  1955-09

3.  Benign histoplasmosis.

Authors:  R LEIGH; H E THOMAS
Journal:  Thorax       Date:  1955-09       Impact factor: 9.139

4.  DIAGNOSIS OF HISTOPLASMOSIS.

Authors:  Allan Jefferson Guimarães; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2006-01       Impact factor: 2.476

5.  Serology of histoplasmosis.

Authors:  H W Larsh; P A Bartels
Journal:  Mycopathol Mycol Appl       Date:  1970

6.  Evaluation of an enzyme-linked immunosorbent assay using purified, deglycosylated histoplasmin for different clinical manifestations of histoplasmosis.

Authors:  Allan Jefferson Guimarães; Claudia Vera Pizzini; Marcos De Abreu Almeida; José Mauro Peralta; Joshua Daniel Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Microbiol Res (Pavia)       Date:  2010-03-17

7.  Histoplasma capsulatum Complement Fixation and Immunodiffusion Assay Sensitivity in Culture-Confirmed Cases of Histoplasmosis: a 10-Year Retrospective Review (2011 to 2020).

Authors:  Madiha Fida; Anisha Misra; Julie A Harring; Aahd Kubbara; Elitza S Theel
Journal:  J Clin Microbiol       Date:  2022-09-12       Impact factor: 11.677

8.  Characterization and evaluation of a soluble antigen complex prepared from the yeast phase of Histoplasma capsulatum.

Authors:  M W Reeves; L Pine; G Bradley
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.